Trichomonas vaginalis is a sexually transmitted protozoan parasite of humans. Treatment of trichomoniasis is almost completely dependent on the old drug metronidazole and is hampered by resistance. New drug development, like routine screening for drug resistance, has however been hampered by the lack of reliable screening protocols with sufficient throughput. Here we report on two separate in vitro protocols that use fluorescent dyes and allow for standardized drug sensitivity testing on the required scale.
CITATION STYLE
Natto, M. J., Eze, A. A., & de Koning, H. P. (2015). Protocols for the routine screening of drug sensitivity in the human parasite trichomonas vaginalis. Methods in Molecular Biology, 1263, 103–110. https://doi.org/10.1007/978-1-4939-2269-7_8
Mendeley helps you to discover research relevant for your work.